PTHrP in Differentiating Human Mesenchymal Stem Cells: Transcript Isoform Expression, Promoter Methylation, and Protein Accumulation
Overview
Authors
Affiliations
Human PTHrP gene displays a complex organization with nine exons producing diverse mRNA variants due to alternative splicing at 5' and 3' ends and the existence of three different transcriptional promoters (P1, P2 and P3), two of which (P2 and P3) contain CpG islands. It is known that the expression of PTHrP isoforms may be differentially regulated in a developmental stage- and tissue-specific manner. To search for novel molecular markers of stemness/differentiation, here we have examined isoform expression in fat-derived mesenchymal stem cells both maintained in stem conditions and induced toward adipo- and osteogenesis. In addition, the expression of the splicing isoforms derived from P2 and P3 promoters was correlated to the state of methylation of the latter. Moreover, we also performed a quantitative evaluation of intracellular and secreted PTHrP protein product in undifferentiated stem cells and in parallel cultures at various differentiation stages. The data obtained indicate that from the stemness condition to that of osteo- and adipo-genic differentiated cells, the expression of isoforms becomes increasingly selective, thereby being a potential gene signature for the monitoring of cell stem or committed/differentiating state and that the switching-off of PTHrP isoform expression is mostly promoter methylation-dependent. Moreover, PTHrP intracellular retention is down-regulated in osteo-differentiating cells whereas the secretion of the protein in the extracellular medium is up-regulated with respect to stem cells, thereby suggesting that these variations of the intracellular and extracellular levels of PTHrP could potentially be enclosed in the list of the available protein signature of osteogenic differentiation.
Ragusa M, Naselli F, Cruciata I, Volpes S, Schimmenti C, Serio G Nutrients. 2023; 15(15).
PMID: 37571432 PMC: 10420994. DOI: 10.3390/nu15153495.
Librizzi M, Naselli F, Abruscato G, Luparello C, Caradonna F Biology (Basel). 2023; 12(7).
PMID: 37508381 PMC: 10376784. DOI: 10.3390/biology12070950.
Shen L, He Y, Chen S, He L, Zhang Y Int J Mol Sci. 2023; 24(8).
PMID: 37108778 PMC: 10146947. DOI: 10.3390/ijms24087616.
Nutritional epigenomic and DNA-damage modulation effect of natural stilbenoids.
Volpes S, Cruciata I, Ceraulo F, Schimmenti C, Naselli F, Pinna C Sci Rep. 2023; 13(1):658.
PMID: 36635363 PMC: 9837110. DOI: 10.1038/s41598-022-27260-1.
Multiple Effects of Resveratrol on Osteosarcoma Cell Lines.
De Luca A, Bellavia D, Raimondi L, Carina V, Costa V, Fini M Pharmaceuticals (Basel). 2022; 15(3).
PMID: 35337142 PMC: 8956103. DOI: 10.3390/ph15030342.